IMMUNATE 250 IU

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

FACTOR VIII HUMAN COAGULATION 250 IU/VIAL

Mevcut itibaren:

TEVA MEDICAL MARKETING LTD.

ATC kodu:

B02BD02

Farmasötik formu:

POWDER FOR SOLUTION FOR INJECTION

Uygulama yolu:

I.V

Tarafından üretildi:

BAXTER AG, AUSTRIA

Terapötik grubu:

COAGULATION FACTOR VIII

Terapötik endikasyonlar:

Treatment and prophylaxis of bleeding in patients with congenital (haemophilia A) or acquired factor VIII deficiency. Von Willebrand's disease with factor VIII deficiency.

Yetkilendirme tarihi:

2011-10-01